A Randomized, Double-blind, Placebo-controlled, Phase 1/2a, Multi-center Clinical Trial for Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain Due to Lumbar Intervertebral Disc Degeneration
Latest Information Update: 31 Aug 2023
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-CHABiotech (Primary)
- Indications Back pain; Intervertebral disc degeneration
- Focus Adverse reactions
- Sponsors CHA Bio & Diostech
- 28 Aug 2023 Status changed from active, no longer recruiting to completed.
- 19 Mar 2023 Planned End Date changed from 30 Apr 2022 to 21 Apr 2023.
- 19 Mar 2023 Planned primary completion date changed from 25 Oct 2020 to 21 Apr 2023.